Invest in HeiQ, invest in impact
Our corporate structure
-
From science to value
We create value by converting frontier science into high‑margin, defensible platforms
-
Brand differentiation
We build differentiation for global brands through performance, sustainability and verified claims
-
Swiss-quality manufacturing
We enable fast commercialization through Swiss‑quality manufacturing across biotech, specialty chemicals and membranes
-
Global co-creation
We scale innovations rapidly through a global network and co‑creation with more than 300 brands in 60 countries
-
De-risk innovation
We de-risk through proven innovation methodology, validated claims, sustainability by design and established industrial readiness)
Why HeiQ wins
-
Deep tech expertise
Strong IP portfolio and deep expertise in biotech, functional chemicals and graphene membranes
-
Awards
- Technology Award twice
- Swiss Environmental Award
- German Sustainability Award
-
Global expert team
200 professionals across five continents focused on turning science into commercial impact
-
Integrated innovation
Unique model that integrates innovation, differentiation and scale‑enablement in one platform
Our advisors
-
Auditor
RPG Crouch Chapman LLP
40 Gracechurch Street
London EC3V 0BT -
Registrar
Computershare Investor Services plc
The Pavilions
Bridgwater Road
Bristol
BS13 8AE
Asset Match platform
HeiQ returned to private ownership and delisted from the London Stock Exchange in November 2024, appointing Asset Match to operate an electronic, off-market dealing facility. Asset Match enables existing shareholders and new investors to trade HeiQ shares through periodic auctions.
Asset Match is an electronic, FCA-regulated marketplace that allows investors to buy and sell shares in private, unquoted companies. It provides liquidity for shareholders wishing to exit private investments and gives institutional or high-net-worth investors access to growth-stage and pre-IPO equities.